A detailed history of Alliancebernstein L.P. transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Alliancebernstein L.P. holds 58,070 shares of WVE stock, worth $825,174. This represents 0.0% of its overall portfolio holdings.

Number of Shares
58,070
Previous 403,984 85.63%
Holding current value
$825,174
Previous $2.02 Million 76.38%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$5.12 - $9.01 $1.77 Million - $3.12 Million
-345,914 Reduced 85.63%
58,070 $476,000
Q2 2024

Aug 14, 2024

BUY
$4.38 - $6.48 $295,190 - $436,719
67,395 Added 20.02%
403,984 $2.02 Million
Q1 2024

May 14, 2024

BUY
$3.54 - $6.84 $1.15 Million - $2.22 Million
324,689 Added 2728.48%
336,589 $2.08 Million
Q4 2023

Feb 14, 2024

BUY
$4.16 - $6.87 $49,504 - $81,753
11,900 New
11,900 $60,000
Q2 2022

Aug 15, 2022

SELL
$1.23 - $3.25 $41,697 - $110,175
-33,900 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$2.0 - $3.28 $4,000 - $6,560
-2,000 Reduced 5.57%
33,900 $68,000
Q4 2021

Feb 14, 2022

SELL
$3.14 - $5.15 $15,072 - $24,720
-4,800 Reduced 11.79%
35,900 $113,000
Q2 2021

Jul 30, 2021

BUY
$5.65 - $7.47 $31,075 - $41,085
5,500 Added 15.63%
40,700 $271,000
Q1 2021

May 06, 2021

SELL
$5.61 - $12.01 $30,294 - $64,854
-5,400 Reduced 13.3%
35,200 $197,000
Q3 2020

Nov 12, 2020

SELL
$8.49 - $19.54 $61,977 - $142,642
-7,300 Reduced 15.24%
40,600 $345,000
Q2 2020

Aug 13, 2020

BUY
$7.44 - $11.29 $74,400 - $112,899
10,000 Added 26.39%
47,900 $499,000
Q1 2020

May 14, 2020

BUY
$6.94 - $14.22 $95,078 - $194,814
13,700 Added 56.61%
37,900 $355,000
Q3 2019

Nov 14, 2019

BUY
$19.17 - $27.4 $46,008 - $65,760
2,400 Added 11.01%
24,200 $497,000
Q1 2019

May 14, 2019

BUY
$32.69 - $47.91 $124,221 - $182,058
3,800 Added 21.11%
21,800 $847,000
Q4 2018

Feb 13, 2019

SELL
$37.1 - $50.11 $25,970 - $35,077
-700 Reduced 3.74%
18,000 $757,000
Q2 2018

Aug 13, 2018

BUY
$33.85 - $50.65 $132,015 - $197,535
3,900 Added 26.35%
18,700 $715,000
Q1 2018

May 14, 2018

BUY
$32.45 - $54.7 $45,430 - $76,580
1,400 Added 10.45%
14,800 $593,000
Q4 2017

Feb 13, 2018

BUY
$21.8 - $39.35 $15,260 - $27,545
700 Added 5.51%
13,400 $470,000
Q3 2017

Nov 13, 2017

BUY
$16.4 - $25.05 $208,279 - $318,135
12,700
12,700 $276,000

Others Institutions Holding WVE

About Wave Life Sciences Ltd.


  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $1.23B
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.